Ownership history in Advisory Services Network, LLC Β· 20 quarters on record
This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in PACIRA PHARMACEUTICALS INC COM (PCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Advisory Services Network, LLC underperformed the S&P 500 by β43.9% annually on this PCRX position. Timing score: 50% (3/6 decisions correct). Average cost basis: $90.26. Maximum drawdown during holding period: β73.4%.
β Significantly underperformed the S&P 500 by 43.9% ann.
19 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
3 of 6 add/trim decisions correct
Best entry: $25.77 (2025 Q3) Β· Worst: $96.92 (2014 Q3)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
3 adds Β· 4 trims. Bought during 2 of 10 down-price quarters. π Predominantly trimming β distribution phase.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size